Cargando…
The relationship between serum p53 autoantibodies and characteristics of human breast cancer.
Sera from 182 newly diagnosed breast cancer patients were assayed for antibodies to p53 using an enzyme-linked immunosorbent assay (ELISA) method, and antibodies were detected in 48 (26%) compared with 1 out of 76 (1.3%) normal control volunteers (P = 0.0001). In breast cancer patients, autoantibodi...
Autores principales: | Mudenda, B., Green, J. A., Green, B., Jenkins, J. R., Robertson, L., Tarunina, M., Leinster, S. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1969453/ https://www.ncbi.nlm.nih.gov/pubmed/8198980 |
Ejemplares similares
-
Serum p53 autoantibodies in patients with minimal lesions of ductal carcinoma in situ of the breast
por: Regele, S, et al.
Publicado: (1999) -
Absence of p53 autoantibodies in a significant proportion of breast cancer patients.
por: Vojtesek, B., et al.
Publicado: (1995) -
Is a histological section representative of whole tumour vascularity in breast cancer?
por: Martin, L., et al.
Publicado: (1997) -
P53 autoantibodies in 1006 patients followed up for breast cancer
por: Metcalfe, Su, et al.
Publicado: (2000) -
Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease.
por: Anandappa, S. Y., et al.
Publicado: (1994)